University of South Alabama
Mobile, Alabama, 36688, United States
Location status: Recruiting
NCT Number: NCT06467695
The goal of this clinical trial is to determine the relative efficacy of fMRI model guided Transcranial Direct Current Stimulation (mgTDCS) in improving the depressive symptoms of patients with Parkinson's Disease (PD). The main questions it aims to answer are: 1) Can the use of mgTDCS significantly improve the self-reported level of depression and apathy in patients with PD from pre-intervention to post-intervention compared to a sham control? 2) Can the use of mgTDCS significantly normalize the cortical eeg alpha asymmetry so commonly seen in depressed patients compared to sham mgTDCS? 3) Can the use of mgTDCS significantly improve scores on neuropsychological tests of working memory?
Interested in participating?
Request Info19 year–65 year
All sexes
Interventional
Not applicable
Mobile, Alabama, 36688, United States
Location status: Recruiting
This study seeks to expand the growing body of literature on the use of a particular type of low voltage electrical stimulation known as Transcranial Direct Current Stimulation (TDCS) to reduce the symptoms of Parkinson's Disease (PD). One common disorder that can result from, and/or be exacerbated by PD is Major Depressive Disorder. In particular, apathy has been noted as a common and detrimental component for those with PD. While many studies have been performed on PD patients using TDCS, the consensus in the literature is that results are widely variable.
Participants will:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Transcranial Electrical Stimulator
Transcranial Electrical Stimulator set to 0 amps
Time frame: One at Day 1 and one after 15 sessions of training, typically 4 weeks after study start.
The BDI, a self-report measure for assessing depression, has high internal consistency (Cronbach's alpha > .90) and good test-retest reliability.
Time frame: One at Day 1 and one after 15 sessions of training, typically 4 weeks after study start.
Alpha band power from pre-post eeg records will be assessed for power changes at frontal sites.
Time frame: One at Day 1 and one after 15 sessions of training, typically 4 weeks after study start.
Digit Span and Story Memory subtests will be used to determine changes in working memory.
Time frame: One at Day 1 and one after 15 sessions of training, typically 4 weeks after study start.
This a common measure to assess patient quality of life in Parkinson Disease patients involved in research.
Contact information is provided by the study sponsor or research team.
Benjamin D Hill, PhD
CONTACT
John F Shelley-Tremblay, PhD
CONTACT
University of South Alabama
Other
The Effect of MRI-Guided Transcranial Direct Current Stimulation on Cognitive and Affective Symptoms in Persons With Parkinson's Disease and Controls
Acronym: LVESDIPP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05585827
Anxiety, Anxiety Disorders
Stavanger, Norway
View Trial DetailsNCT06455293
Basal Ganglia Diseases, Behavior
San Francisco, California, United States
View Trial DetailsNCT05568498
Basal Ganglia Diseases, Behavior
Vancouver, British Columbia, Canada
View Trial DetailsNCT03217110
Autism Spectrum Disorder, Basal Ganglia Diseases
Iowa City, Iowa, United States
View Trial Details